Biology of Zika virus infection in human skin cells

Journal of Virology

Volumn 89, Issue 17, 2015, Pages 8880-8896

  Hamel, Rodolphe ^a   Dejarnac, Ophélie ^b   Wichit, Sineewanlaya ^a   Ekchariyawat, Peeraya ^a   Neyret, Aymeric ^a   Luplertlop, Natthanej ^c   Perera Lecoin, Manuel ^a   Surasombatpattana, Pornapat ^d   Talignani, Loïc ^a   Thomas, Frédéric ^a   Cao Lormeau, Van Mai ^e   Choumet, Valérie ^f   Briant, Laurence ^a   Desprès, Philippe ^f,g   Amara, Ali ^b   Yssel, Hans ^h   Missé, Dorothée ^a  

^a CNRS   (France)

^b INSERM   (France)

^c MAHIDOL UNIVERSITY   (Thailand)

^d PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^e INSTITUT LOUIS MALARDÉ   (French Polynesia)

^f INSTITUT PASTEUR   (France)

^g UNIVERSITÉ DE LA RÉUNION   (France)

^h PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLADENINE; BETA INTERFERON; CD209 ANTIGEN; FIBRONECTIN; KIDNEY INJURY MOLECULE 1; NEUTRALIZING ANTIBODY; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR 3; AXL RECEPTOR TYROSINE KINASE; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; CYTOKINE; DC-SPECIFIC ICAM-3 GRABBING NONINTEGRIN; DDX58 PROTEIN, HUMAN; DEAD BOX PROTEIN; HAVCR1 PROTEIN, HUMAN; IFIH1 PROTEIN, HUMAN; INTERFERON INDUCED HELICASE C DOMAIN CONTAINING PROTEIN 1; ISG15 PROTEIN, HUMAN; LECTIN; MEMBRANE PROTEIN; MX1 PROTEIN, HUMAN; MYXOVIRUS RESISTANCE PROTEIN; ONCOPROTEIN; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA; TLR3 PROTEIN, HUMAN; TLR7 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 7; TYRO3 PROTEIN, HUMAN; UBIQUITIN; VIRUS RECEPTOR;

ADULT; ARBOVIRUS; ARTICLE; AUTOPHAGOSOME; CONTROLLED STUDY; DENDRITIC CELL; FIBROBLAST; FRENCH POLYNESIA; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; ISG15 GENE; KERATINOCYTE; MX1 GENE; NEWBORN; OAS2 GENE; PRIORITY JOURNAL; SKIN CELL; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS GENE; VIRUS INFECTION; VIRUS ISOLATION; VIRUS REPLICATION; ZIKA VIRUS; ZIKA VIRUS INFECTION; AEDES; ANIMAL; AUTOPHAGY; BIOSYNTHESIS; CELL CULTURE; CHLOROCEBUS AETHIOPS; FLAVIVIRIDAE; FLAVIVIRIDAE INFECTION; GENETICS; HEK293 CELL LINE; IMMUNOLOGY; INSECT VECTOR; METABOLISM; PHAGOSOME; PHYSIOLOGY; RNA INTERFERENCE; SKIN; VERO CELL LINE; VIROLOGY;

ARBOVIRUS; FLAVIVIRIDAE; FLAVIVIRUS; JAPANESE ENCEPHALITIS VIRUS GROUP; ZIKA VIRUS;

AEDES; ANIMALS; AUTOPHAGY; CELL ADHESION MOLECULES; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; CYTOKINES; DEAD BOX PROTEIN 58; DEAD-BOX RNA HELICASES; DENDRITIC CELLS; FIBROBLASTS; FLAVIVIRIDAE; FLAVIVIRIDAE INFECTIONS; HEK293 CELLS; HEPATITIS A VIRUS CELLULAR RECEPTOR 1; HUMANS; INSECT VECTORS; INTERFERON-BETA; INTERFERON-INDUCED HELICASE, IFIH1; KERATINOCYTES; LECTINS, C-TYPE; MEMBRANE GLYCOPROTEINS; MYXOVIRUS RESISTANCE PROTEINS; PHAGOSOMES; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CELL SURFACE; RECEPTORS, VIRUS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SKIN; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 7; UBIQUITINS; VERO CELLS; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 84938919218     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00354-15     Document Type: Article

References (64)

1. Kuno G, Chang GJ, Tsuchiya KR, Karabatsos N, Cropp CB. 1998. Phylogeny of the genus Flavivirus. J Virol 72:73-83.
2. Moore DL, Causey OR, Carey DE, Reddy S, Cooke AR, Akinkugbe FM, David-West TS, Kemp GE. 1975. Arthropod-borne viral infections of man in Nigeria, 1964-1970. Ann Trop Med Parasitol 69:49-64.
3. Simpson DI. 1964. Zika virus infection in man. Trans R Soc Trop Med Hyg 58:335-338. http://dx.doi.org/10.1016/0035-9203(64)90200-7.
4. Smithburn KC. 1954. Neutralizing antibodies against arthropod-borne viruses in the sera of long-time residents of Malaya and Borneo. Am J Hyg 59:157-163.
5. Fagbami AH. 1979. Zika virus infections in Nigeria: virological and seroepidemiological investigations in Oyo State. J Hyg 83:213-219. http://dx.doi.org/10.1017/S0022172400025997.
6. Hammon WM, Schrack WD, Sather GE. 1958. Serological survey for a arthropod-borne virus infections in the Philippines. Am J Trop Med Hyg 7:323-328.
7. Pond WL. 1963. Arthropod-borne virus antibodies in sera from residents of South-East Asia. Trans R Soc Trop Med Hyg 57:364-371. http://dx.doi.org/10.1016/0035-9203(63)90100-7.
8. Olson JG, Ksiazek TG, Suhandiman, Triwibowo. 1981. Zika virus, a cause of fever in Central Java, Indonesia. Trans R Soc Trop Med Hyg 75:389-393. http://dx.doi.org/10.1016/0035-9203(81)90100-0.
9. Darwish MA, Hoogstraal H, Roberts TJ, Ghazi R, Amer T. 1983. A sero-epidemiological survey for Bunyaviridae and certain other arboviruses in Pakistan. Trans R Soc Trop Med Hyg 77:446-450. http://dx.doi.org/10.1016/0035-9203(83)90108-6.
10. Marchette NJ, Garcia R, Rudnick A. 1969. Isolation of Zika virus from Aedes aegypti mosquitoes in Malaysia. Am J Trop Med Hyg 18:411-415.
11. Li MI, Wong PS, Ng LC, Tan CH. 2012. Oral susceptibility of Singapore Aedes (Stegomyia) aegypti (Linnaeus) to Zika virus. PLoS Negl Trop Dis 6:e1792. http://dx.doi.org/10.1371/journal.pntd.0001792.
12. Boorman JP, Porterfield JS. 1956. A simple technique for infection of mosquitoes with viruses; transmission of Zika virus. Trans R Soc Trop Med Hyg 50:238-242. http://dx.doi.org/10.1016/0035-9203(56)90029-3.
13. Monlun E, Zeller H, Le Guenno B, Traoré-Lamizana M, Hervy JP, Adam F, Ferrara L, Fontenille D, Sylla R, Mondo M. 1993. Surveillance of the circulation of arbovirus of medical interest in the region of eastern Senegal. Bull Soc Pathol Exot 86:21-28.
14. Weinbren MP, Williams MC. 1958. Zika virus: further isolations in the Zika area, and some studies on the strains isolated. Trans R Soc Trop Med Hyg 52:263-268. http://dx.doi.org/10.1016/0035-9203(58)90085-3.
15. Haddow AJ, Williams MC, Woodall JP, Simpson DI, Goma LK. 1964. Twelve isolations of Zika virus from Aedes (Stegomyia) africanus (Theobald) taken in and above a Uganda forest. Bull World Health Organ 31: 57-69.
16. Haddow AD, Schuh AJ, Yasuda CY, Kasper MR, Heang V, Huy R, Guzman H, Tesh RB, Weaver SC. 2012. Genetic characterization of Zika virus strains: geographic expansion of the Asian lineage. PLoS Negl Trop Dis 6:e1477. http://dx.doi.org/10.1371/journal.pntd.0001477.
17. Duffy MR, Chen TH, Hancock WT, Powers AM, Kool JL, Lanciotti RS, Pretrick M, Marfel M, Holzbauer S, Dubray C, Guillaumot L, Griggs A, Bel M, Lambert AJ, Laven J, Kosoy O, Panella A, Biggerstaff BJ, Fischer M, Hayes EB. 2009. Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med 360:2536-2543. http://dx.doi.org/10.1056/NEJMoa0805715.
18. Musso D, Nilles EJ, Cao-Lormeau VM. 2014. Rapid spread of emerging Zika virus in the Pacific area. Clin Microbiol Infect 20:O595-O596. http://dx.doi.org/10.1111/1469-0691.12707.
19. Kwong JC, Druce JD, Leder K. 2013. Zika virus infection acquired during brief travel to Indonesia. Am J Trop Med Hyg 89:516-517. http://dx.doi.org/10.4269/ajtmh.13-0029.
20. Tappe D, Rissland J, Gabriel M, Emmerich P, Gunther S, Held G, Smola S, Schmidt-Chanasit J. 2014. First case of laboratory-confirmed Zika virus infection imported into Europe, November 2013. Euro Surveill 19:20685.
21. Pyke AT, Daly MT, Cameron JN, Moore PR, Taylor CT, Hewitson GR, Humphreys JL, Gair R. 2014. Imported Zika virus infection from the Cook Islands into Australia, 2014. PLoS Curr 6:ecurrents.outbreaks. 4635a54dbffba2156fb2fd76dc49f65e. http://dx.doi.org/10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e.
22. Fonseca K, Meatherall B, Zarra D, Drebot M, MacDonald J, Pabbaraju K, Wong S, Webster P, Lindsay R, Tellier R. 2014. First case of Zika virus infection in a returning Canadian traveler. Am J Trop Med Hyg 91:1035-1038. http://dx.doi.org/10.4269/ajtmh.14-0151.
23. Oehler E, Watrin L, Larre P, Leparc-Goffart I, Lastere S, Valour F, Baudouin L, Mallet H, Musso D, Ghawche F. 2014. Zika virus infection complicated by Guillain-Barre syndrome-case report, French Polynesia, December 2013. Euro Surveill 19:20720.
24. Briant L, Desprès P, Choumet V, Missé D. 2014. Role of skin immune cells on the host susceptibility to mosquito-borne viruses. Virology 464-465:26-32. http://dx.doi.org/10.1016/j.virol.2014.06.023.
25. Surasombatpattana P, Hamel R, Patramool S, Luplertlop N, Thomas F, Despres P, Briant L, Yssel H, Misse D. 2011. Dengue virus replication in infected human keratinocytes leads to activation of antiviral innate immune responses. Infect Genet Evol 11:1664-1673. http://dx.doi.org/10.1016/j.meegid.2011.06.009.
26. Meertens L, Carnec X, Lecoin MP, Ramdasi R, Guivel-Benhassine F, Lew E, Lemke G, Schwartz O, Amara A. 2012. The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry. Cell Host Microbe 12:544-557. http://dx.doi.org/10.1016/j.chom.2012.08.009.
27. Limon-Flores AY, Perez-Tapia M, Estrada-Garcia I, Vaughan G, Escobar-Gutierrez A, Calderon-Amador J, Herrera-Rodriguez SE, Brizuela-Garcia A, Heras-Chavarria M, Flores-Langarica A, Cedillo-Barron L, Flores-Romo L. 2005. Dengue virus inoculation to human skin explants: an effective approach to assess in situ the early infection and the effects on cutaneous dendritic cells. Int J Exp Pathol 86:323-334. http://dx.doi.org/10.1111/j.0959-9673.2005.00445.x.
28. Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Johnson AJ, Stanfield SM, Duffy MR. 2008. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 14:1232-1239. http://dx.doi.org/10.3201/eid1408.080287.
29. Perera-Lecoin M, Meertens L, Carnec X, Amara A. 2014. Flavivirus entry receptors: an update. Viruses 6:69-88. http://dx.doi.org/10.3390/v6010069.
30. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, Shimada N, Ohba Y, Takaoka A, Yoshida N, Taniguchi T. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434:772-777. http://dx.doi.org/10.1038/nature03464.
31. Dick GW, Kitchen SF, Haddow AJ. 1952. Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg 46:509-520. http://dx.doi.org/10.1016/0035-9203(52)90042-4.
32. Lim PY, Behr MJ, Chadwick CM, Shi PY, Bernard KA. 2011. Keratinocytes are cell targets of West Nile virus in vivo. J Virol 85:5197-5201. http://dx.doi.org/10.1128/JVI.02692-10.
33. Cerny D, Haniffa M, Shin A, Bigliardi P, Tan BK, Lee B, Poidinger M, Tan EY, Ginhoux F, Fink K. 2014. Selective susceptibility of human skin antigen presenting cells to productive dengue virus infection. PLoS Pathog 10:e1004548. http://dx.doi.org/10.1371/journal.ppat.1004548.
34. Chen Y, Maguire T, Hileman RE, Fromm JR, Esko JD, Linhardt RJ, Marks RM. 1997. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med 3:866-871. http://dx.doi.org/10.1038/nm0897-866.
35. Germi R, Crance JM, Garin D, Guimet J, Lortat-Jacob H, Ruigrok RW, Zarski JP, Drouet E. 2002. Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus. Virology 292:162-168. http://dx.doi.org/10.1006/viro.2001.1232.
36. Hilgard P, Stockert R. 2000. Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes. Hepatology 32:1069-1077. http://dx.doi.org/10.1053/jhep.2000.18713.
37. Kroschewski H, Allison SL, Heinz FX, Mandl CW. 2003. Role of heparan sulfate for attachment and entry of tick-borne encephalitis virus. Virology 308:92-100. http://dx.doi.org/10.1016/S0042-6822(02)00097-1.
38. Lee E, Pavy M, Young N, Freeman C, Lobigs M. 2006. Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses. Antiviral Res 69:31-38. http://dx.doi.org/10.1016/j.antiviral.2005.08.006.
39. Navarro-Sanchez E, Altmeyer R, Amara A, Schwartz O, Fieschi F, Virelizier JL, Arenzana-Seisdedos F, Despres P. 2003. Dendritic-cellspecific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep 4:723-728. http://dx.doi.org/10.1038/sj.embor.embor866.
40. Tassaneetrithep B, Burgess TH, Granelli-Piperno A, Trumpfheller C, Finke J, Sun W, Eller MA, Pattanapanyasat K, Sarasombath S, Birx DL, Steinman RM, Schlesinger S, Marovich MA. 2003. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med 197: 823-829. http://dx.doi.org/10.1084/jem.20021840.
41. Chen ST, Lin YL, Huang MT, Wu MF, Cheng SC, Lei HY, Lee CK, Chiou TW, Wong CH, Hsieh SL. 2008. CLEC5A is critical for denguevirus-induced lethal disease. Nature 453:672-676. http://dx.doi.org/10.1038/nature07013.
42. Lemke G, Rothlin CV. 2008. Immunobiology of the TAM receptors. Nat Rev Immunol 8:327-336. http://dx.doi.org/10.1038/nri2303.
43. Fredericksen BL, Keller BC, Fornek J, Katze MG, Gale M. 2008. Establishment and maintenance of the innate antiviral response to West Nile virus involves both RIG-I and MDA5 signaling through IPS-1. J Virol 82:609-616. http://dx.doi.org/10.1128/JVI.01305-07.
44. Bustos-Arriaga J, Garcia-Machorro J, Leon-Juarez M, Garcia-Cordero J, Santos-Argumedo L, Flores-Romo L, Mendez-Cruz AR, Juarez-Delgado FJ, Cedillo-Barron L. 2011. Activation of the innate immune response against DENV in normal non-transformed human fibroblasts. PLoS Negl Trop Dis 5:e1420. http://dx.doi.org/10.1371/journal.pntd.0001420.
45. Nazmi A, Dutta K, Hazra B, Basu A. 2014. Role of pattern recognition receptors in flavivirus infections. Virus Res 185:32-40. http://dx.doi.org/10.1016/j.virusres.2014.03.013.
46. Paladino P, Cummings DT, Noyce RS, Mossman KL. 2006. The IFNindependent response to virus particle entry provides a first line of antiviral defense that is independent of TLRs and retinoic acid-inducible gene I. J Immunol 177:8008-8016. http://dx.doi.org/10.4049/jimmunol.177.11.8008.
47. Proost P, Vynckier AK, Mahieu F, Put W, Grillet B, Struyf S, Wuyts A, Opdenakker G, Van Damme J. 2003. Microbial Toll-like receptor ligands differentially regulate CXCL10/IP-10 expression in fibroblasts and mononuclear leukocytes in synergy with IFN-gamma and provide a mechanism for enhanced synovial chemokine levels in septic arthritis. Eur J Immunol 33:3146-3153. http://dx.doi.org/10.1002/eji.200324136.
48. Bourne N, Scholle F, Silva MC, Rossi SL, Dewsbury N, Judy B, De Aguiar JB, Leon MA, Estes DM, Fayzulin R, Mason PW. 2007. Early production of type I interferon during West Nile virus infection: role for lymphoid tissues in IRF3-independent interferon production. J Virol 81: 9100-9108. http://dx.doi.org/10.1128/JVI.00316-07.
49. Xie Z, Klionsky DJ. 2007. Autophagosome formation: core machinery and adaptations. Nat Cell Biol 9:1102-1109. http://dx.doi.org/10.1038/ncb1007-1102.
50. Shelly S, Lukinova N, Bambina S, Berman A, Cherry S. 2009. Autophagy is an essential component of Drosophila immunity against vesicular stomatitis virus. Immunity 30:588-598. http://dx.doi.org/10.1016/j.immuni.2009.02.009.
51. Lee HK, Lund JM, Ramanathan B, Mizushima N, Iwasaki A. 2007. Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 315:1398-1401. http://dx.doi.org/10.1126/science.1136880.
52. Tallóczy Z, Virgin HW, Levine B. 2006. PKR-dependent autophagic degradation of herpes simplex virus type 1. Autophagy 2:24-29. http://dx.doi.org/10.4161/auto.2176.
53. Lee YR, Lei HY, Liu MT, Wang JR, Chen SH, Jiang-Shieh YF, Lin YS, Yeh TM, Liu CC, Liu HS. 2008. Autophagic machinery activated by dengue virus enhances virus replication. Virology 374:240-248. http://dx.doi.org/10.1016/j.virol.2008.02.016.
54. Heaton NS, Randall G. 2011. Dengue virus and autophagy. Viruses 3:1332-1341. http://dx.doi.org/10.3390/v3081332.
55. Krejbich-Trotot P, Gay B, Li-Pat-Yuen G, Hoarau JJ, Jaffar-Bandjee MC, Briant L, Gasque P, Denizot M. 2011. Chikungunya triggers an autophagic process which promotes viral replication. Virol J 8:432. http://dx.doi.org/10.1186/1743-422X-8-432.
56. Li JK, Liang JJ, Liao CL, Lin YL. 2012. Autophagy is involved in the early step of Japanese encephalitis virus infection. Microbes Infect 14:159-168. http://dx.doi.org/10.1016/j.micinf.2011.09.001.
57. Vandergaast R, Fredericksen BL. 2012. West Nile virus (WNV) replication is independent of autophagy in mammalian cells. PLoS One 7:e45800. http://dx.doi.org/10.1371/journal.pone.0045800.
58. Panyasrivanit M, Greenwood MP, Murphy D, Isidoro C, Auewarakul P, Smith DR. 2011. Induced autophagy reduces virus output in dengue infected monocytic cells. Virology 418:74-84. http://dx.doi.org/10.1016/j.virol.2011.07.010.
59. Ke PY, Chen SS. 2011. Activation of the unfolded protein response and autophagy after hepatitis C virus infection suppresses innate antiviral immunity in vitro. J Clin Invest 121:37-56. http://dx.doi.org/10.1172/JCI41474.
60. Dreux M, Gastaminza P, Wieland SF, Chisari FV. 2009. The autophagy machinery is required to initiate hepatitis C virus replication. Proc Natl Acad Sci U S A 106:14046-14051. http://dx.doi.org/10.1073/pnas.0907344106.
61. Heaton NS, Randall G. 2010. Dengue virus-induced autophagy regulates lipid metabolism. Cell Host Microbe 8:422-432. http://dx.doi.org/10.1016/j.chom.2010.10.006.
62. Grard G, Caron M, Mombo IM, Nkoghe D, Mboui Ondo S, Jiolle D, Fontenille D, Paupy C, Leroy EM. 2014. Zika virus in Gabon (Central Africa)-2007: a new threat from Aedes albopictus? PLoS Negl Trop Dis 8:e2681. http://dx.doi.org/10.1371/journal.pntd.0002681.
63. Benedict MQ, Levine RS, Hawley WA, Lounibos LP. 2007. Spread of the tiger: global risk of invasion by the mosquito Aedes albopictus. Vector Borne Zoonotic Dis 7:76-85. http://dx.doi.org/10.1089/vbz.2006.0562.
64. Medlock JM, Hansford KM, Schaffner F, Versteirt V, Hendrickx G, Zeller H, Van Bortel W. 2012. A review of the invasive mosquitoes in Europe: ecology, public health risks, and control options. Vector Borne Zoonotic Dis 12:435-447. http://dx.doi.org/10.1089/vbz.2011.0814.